Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;182(6):496-514.
doi: 10.1159/000513811. Epub 2021 Feb 25.

Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview

Ana I Tabar  1   2 , Julio Delgado  3 , Eloina González-Mancebo  4   5 , Esozia Arroabarren  6 , Lorena Soto Retes  7   8 , Javier Domínguez-Ortega  9 ; Spanish Allergy and Clinical Immunology Scientific Society (SEAIC)
Affiliations
Free article
Review

Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview

Ana I Tabar et al. Int Arch Allergy Immunol. 2021.
Free article

Abstract

The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.

Keywords: Allergy; Asthma; Clinical practice; Immunotherapy.

PubMed Disclaimer